| 931 |
PHENIGAN |
PROMETHAZINE HYDROCHLORIDE 50MG/2ML |
INJECTION |
AMPOULES |
ANTIHISTAMINIC |
Yes |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
07 L 0102/94 |
2023-08-29 |
2026-08-28 |
View |
| 932 |
PHOBEDA |
BEDAQUILINE 100 MG |
TABLET |
BOTTLE |
AS PART OF COMBINATION THERAPY IN THE TREATMENT OF ADULT AND PAEDIATRIC PATIENTS WITH PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS |
No |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
05 L 0972/23 |
2023-05-17 |
2026-05-16 |
View |
| 933 |
MENDAZOL |
MEBENDAZOL 500MG |
TABLET |
BLISTERPACK |
|
Yes |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
07 L 0306/98 |
2024-09-24 |
2027-09-23 |
View |
| 934 |
PHOCLASCO |
CLASCOTERONE 1% |
CREAM |
TUBE |
FOR THE TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OF AGE AND OLDER. |
No |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
03 L 0948/23 |
2023-03-17 |
2026-03-16 |
View |
| 935 |
PHODETA |
DOLUTEGRAVIR 50 MG, EMTRICITABINE 200 MG, TENOFOVIR ALAFENAMIDE 25 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF HIV-1 INFECTION IN ADULT |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
04 L 0905/22 |
2022-04-21 |
2025-04-20 |
View |
| 936 |
PHOELA |
ELAGOLIX 200 MG |
TABLET |
BOTTLE |
RELIEF OF MODERATE TO SEVERE PAIN OF ENDOMETRIOSIS |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
04 L 0907/22 |
2022-04-21 |
2025-04-20 |
View |
| 937 |
PHOELA |
ELAGOLIX 150 MG |
TABLET |
BOTTLE |
FOR THE MANAGEMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
04 L 0908/22 |
2022-05-05 |
2025-05-04 |
View |
| 938 |
PHOFINA |
FINASTERIDE 2 275 MG/ML |
TOPICAL SPRAY |
BOTTLE |
FOR TOPICAL TREATMENT OF MILD TO MODERATE HAIR LOSS (ANDROGENETIC ALOPECIA) TO INCREASE HAIR GROWTH AND PREVENT FURTHER HAIR LOSS |
No |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
03 L 0949/23 |
2023-03-17 |
2026-03-16 |
View |
| 939 |
PHOGILTE |
GILTERITINIB 40 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WHO HAVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION |
No |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
05 L 0973/23 |
2023-05-17 |
2026-05-16 |
View |
| 940 |
PHOLENVA 10 |
LENVATINIB 10 MG |
CAPSULE |
BLISTERPACK |
FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
02 L 0824/20 |
2023-07-31 |
2026-07-30 |
View |
